Payment overview · 2025
General Payments
$142.91
11 reported records · 1 companies
Healthcare provider profile · identity verified
Daniel Keith Spencer, AGPCNP-BC
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner · DUBLIN, VA · NPI 1376927590
Verified facts
What the public records show
CMS Open Payments records show Daniel Keith Spencer, AGPCNP-BC received $142.91 in general payments during 2025 across 11 reported records.
E.R. Squibb & Sons, L.L.C. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
E.R. Squibb & Sons, L.L.C. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 27956 records involving 14870 distinct recipient NPIs. Public Medicare Part D data also shows 78 claims for Eliquis by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | Unresolved — no canonical attribution shown | $142.91 | 100.0% | 11 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $142.91 | 11 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| COBENFY Normalized: cobenfy |
Drug | E.R. Squibb & Sons, L.L.C. | $142.91 | 11 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 27956 supporting records · 14870 recipient NPIs · example record 1184377713 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
78 | 11 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Lisinopril | Lisinopril | 925 | 106 |
| Atorvastatin Calcium | Atorvastatin Calcium | 696 | 85 |
| Furosemide | Furosemide | 666 | 76 |
| Levothyroxine Sodium | Levothyroxine Sodium | 654 | 71 |
| Omeprazole | Omeprazole | 459 | 56 |
| Hydrochlorothiazide | Hydrochlorothiazide | 453 | 56 |
| Metformin Hcl | Metformin Hcl | 425 | 56 |
| Carvedilol | Carvedilol | 422 | 57 |
| Famotidine | Famotidine | 395 | 70 |
| Gabapentin | Gabapentin | 393 | 45 |
| Metoprolol Tartrate | Metoprolol Tartrate | 387 | 45 |
| Propranolol Hcl | Propranolol Hcl | 375 | 47 |
| Pantoprazole Sodium | Pantoprazole Sodium | 344 | 39 |
| Potassium Chloride | Potassium Chloride | 339 | 43 |
| Amlodipine Besylate | Amlodipine Besylate | 334 | 47 |
| Metformin Hcl Er | Metformin Hcl | 263 | 23 |
| Montelukast Sodium | Montelukast Sodium | 254 | 28 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 229 | 32 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 223 | 27 |
| Naproxen | Naproxen | 222 | 34 |
| Tamsulosin Hcl | Tamsulosin Hcl | 221 | 29 |
| Trazodone Hcl | Trazodone Hcl | 209 | 38 |
| Ibuprofen | Ibuprofen | 207 | 52 |
| Donepezil Hcl | Donepezil Hcl | 199 | 27 |
| Memantine Hcl | Memantine Hcl | 197 | 24 |
| Olanzapine | Olanzapine | 191 | 21 |
| Escitalopram Oxalate | Escitalopram Oxalate | 189 | 29 |
| Benztropine Mesylate | Benztropine Mesylate | 188 | 30 |
| Spironolactone | Spironolactone | 181 | 25 |
| Divalproex Sodium | Divalproex Sodium | 179 | 22 |
| Simvastatin | Simvastatin | 177 | 19 |
| Glipizide | Glipizide | 176 | 21 |
| Quetiapine Fumarate | Quetiapine Fumarate | 170 | 25 |
| Aripiprazole | Aripiprazole | 169 | 26 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 159 | 19 |
| Losartan Potassium | Losartan Potassium | 157 | 23 |
| Sertraline Hcl | Sertraline Hcl | 145 | 19 |
| Prednisone | Prednisone | 144 | 63 |
| Risperidone | Risperidone | 142 | 18 |
| Loperamide | Loperamide Hcl | 141 | 37 |
| Levetiracetam | Levetiracetam | 137 | 16 |
| Fluticasone Propionate | Fluticasone Propionate | 131 | 27 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 128 | 17 |
| Lactulose | Lactulose | 115 | 23 |
| Constulose | Lactulose | 113 | 17 |
| Fluoxetine Hcl | Fluoxetine Hcl | 111 | 13 |
| Diclofenac Sodium | Diclofenac Sodium | 106 | 19 |
| Breo Ellipta | Fluticasone/Vilanterol | 104 | 11 |
| Gemfibrozil | Gemfibrozil | 102 | 15 |
| Buspirone Hcl | Buspirone Hcl | 99 | 19 |
| Mirtazapine | Mirtazapine | 96 | 17 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 89 | suppressed |
| Clonazepam | Clonazepam | 89 | 18 |
| Meloxicam | Meloxicam | 89 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 87 | 12 |
| Oxybutynin Chloride | Oxybutynin Chloride | 87 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 81 | 11 |
| Nystatin | Nystatin | 81 | 40 |
| Clopidogrel | Clopidogrel Bisulfate | 80 | 11 |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 79 | 11 |
| Mupirocin | Mupirocin | 79 | 47 |
| Eliquis | Apixaban | 78 | 11 |
| Azithromycin | Azithromycin | 77 | 58 |
| Pravastatin Sodium | Pravastatin Sodium | 77 | suppressed |
| Metolazone | Metolazone | 75 | 17 |
| Ropinirole Hcl | Ropinirole Hcl | 73 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 72 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 72 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 70 | 28 |
| Incruse Ellipta | Umeclidinium Bromide | 67 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 63 | 11 |
| Dexamethasone | Dexamethasone | 63 | 53 |
| Spiriva Handihaler | Tiotropium Bromide | 63 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 63 | 13 |
| Duloxetine Hcl | Duloxetine Hcl | 59 | suppressed |
| Fluconazole | Fluconazole | 58 | 17 |
| Novolog | Insulin Aspart | 58 | 11 |
| Invega Sustenna | Paliperidone Palmitate | 57 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 57 | 11 |
| Lorazepam | Lorazepam | 56 | 12 |
| Divalproex Sodium Er | Divalproex Sodium | 50 | 11 |
| Humalog | Insulin Lispro | 50 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 50 | 11 |
| Alendronate Sodium | Alendronate Sodium | 49 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 49 | 14 |
| Alcohol Swabs | Alcohol Antiseptic Pads | 48 | suppressed |
| Levofloxacin | Levofloxacin | 48 | 40 |
| Paroxetine Hcl | Paroxetine Hcl | 48 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 48 | suppressed |
| Lovastatin | Lovastatin | 47 | suppressed |
| Novolog Flexpen | Insulin Aspart | 47 | suppressed |
| Advocate Pen Needles | Pen Needle, Diabetic | 46 | suppressed |
| Ketoconazole | Ketoconazole | 46 | 16 |
| Metoprolol Succinate | Metoprolol Succinate | 46 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 45 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 45 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 45 | 32 |
| Diltiazem Hcl | Diltiazem Hcl | 44 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 44 | suppressed |
| Januvia | Sitagliptin Phosphate | 44 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 44 | suppressed |
| Veo Insulin Syringe | Syringe-Needle,insulin,0.5 Ml | 42 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 41 | suppressed |
| Pregabalin | Pregabalin | 41 | suppressed |
| Haloperidol Decanoate | Haloperidol Decanoate | 40 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 40 | 13 |
| Fentanyl | Fentanyl | 39 | suppressed |
| Glimepiride | Glimepiride | 39 | suppressed |
| Cephalexin | Cephalexin | 38 | 30 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 38 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 38 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 37 | 15 |
| Doxycycline Hyclate | Doxycycline Hyclate | 37 | 29 |
| Topiramate | Topiramate | 37 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 36 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 36 | suppressed |
| Single Use Swab | Alcohol Antiseptic Pads | 35 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 34 | suppressed |
| Atenolol | Atenolol | 34 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 34 | suppressed |
| Latanoprost | Latanoprost | 34 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 33 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 33 | suppressed |
| Metronidazole | Metronidazole | 33 | suppressed |
| Ibu | Ibuprofen | 32 | suppressed |
| Methimazole | Methimazole | 32 | suppressed |
| Admelog Solostar | Insulin Lispro | 31 | suppressed |
| Fenofibrate | Fenofibrate | 31 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 30 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 30 | suppressed |
| Digoxin | Digoxin | 29 | suppressed |
| Droplet Pen Needle | Pen Needle, Diabetic | 29 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 29 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 29 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 29 | suppressed |
| Ramelteon | Ramelteon | 29 | suppressed |
| Belsomra | Suvorexant | 28 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 28 | suppressed |
| Levemir | Insulin Detemir | 28 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 28 | 17 |
| Tresiba Flextouch U-100 | Insulin Degludec | 28 | suppressed |
| Finasteride | Finasteride | 27 | suppressed |
| Insulin Syringe | Syringe-Needle,insulin,0.5 Ml | 26 | suppressed |
| Lamotrigine | Lamotrigine | 26 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 26 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 26 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 25 | 17 |
| Easy Touch | Syringe-Needle,insulin,0.5 Ml | 25 | suppressed |
| Ozempic | Semaglutide | 25 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 25 | suppressed |
| Allopurinol | Allopurinol | 24 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 24 | 21 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 24 | suppressed |
| Xarelto | Rivaroxaban | 24 | suppressed |
| Bupropion Xl | Bupropion Hcl | 22 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 22 | suppressed |
| Nitroglycerin | Nitroglycerin | 22 | 13 |
| Pioglitazone Hcl | Pioglitazone Hcl | 22 | suppressed |
| Rivastigmine | Rivastigmine | 22 | suppressed |
| Myrbetriq | Mirabegron | 21 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 20 | suppressed |
| Lidocaine-Prilocaine | Lidocaine/Prilocaine | 20 | suppressed |
| Ondansetron Odt | Ondansetron | 20 | 12 |
| Oxcarbazepine | Oxcarbazepine | 20 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 20 | suppressed |
| Semglee (Yfgn) Pen | Insulin Glargine-Yfgn | 20 | suppressed |
| Sucralfate | Sucralfate | 20 | suppressed |
| Admelog | Insulin Lispro | 19 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 19 | suppressed |
| Diltiazem 12hr Er | Diltiazem Hcl | 19 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 19 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 19 | suppressed |
| Alprazolam | Alprazolam | 18 | suppressed |
| Clozapine | Clozapine | 18 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 18 | suppressed |
| Lidocaine Hcl Viscous | Lidocaine Hcl | 18 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 18 | suppressed |
| Advocate Pen Needle | Pen Needle, Diabetic | 17 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 17 | 12 |
| Pulmicort Flexhaler | Budesonide | 17 | suppressed |
| Hydrocortisone | Hydrocortisone | 16 | suppressed |
| Mounjaro | Tirzepatide | 16 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 16 | 16 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 16 | 15 |
| Fluphenazine Hcl | Fluphenazine Hcl | 15 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 15 | suppressed |
| Mesalamine Dr | Mesalamine | 15 | suppressed |
| Nystop | Nystatin | 15 | suppressed |
| Ulticare Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 15 | suppressed |
| Asenapine Maleate | Asenapine Maleate | 14 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 14 | 12 |
| Ramipril | Ramipril | 14 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 13 | suppressed |
| Amlodipine-Atorvastatin | Amlodipine/Atorvastatin | 13 | suppressed |
| Brilinta | Ticagrelor | 13 | suppressed |
| Carbamazepine | Carbamazepine | 13 | suppressed |
| Celecoxib | Celecoxib | 13 | suppressed |
| Ezetimibe | Ezetimibe | 13 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 13 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 13 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 13 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 13 | suppressed |
| Nyamyc | Nystatin | 13 | suppressed |
| Phenytoin | Phenytoin | 13 | suppressed |
| Roflumilast | Roflumilast | 13 | suppressed |
| Safetyglide Insulin Syringe | Syringe,needle,insuln,sf 0.5ml | 13 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 13 | suppressed |
| Zenpep | Lipase/Protease/Amylase | 13 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 13 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 12 | suppressed |
| Amoxicillin | Amoxicillin | 12 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 12 | suppressed |
| Chlorthalidone | Chlorthalidone | 12 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 12 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 12 | suppressed |
| Imipramine Hcl | Imipramine Hcl | 12 | suppressed |
| Jardiance | Empagliflozin | 12 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 12 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 12 | suppressed |
| Phenobarbital | Phenobarbital | 12 | suppressed |
| Polymyxin B Sul-Trimethoprim | Polymyxin B Sulf/Trimethoprim | 12 | suppressed |
| Pradaxa | Dabigatran Etexilate Mesylate | 12 | suppressed |
| Ranolazine Er | Ranolazine | 12 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 12 | suppressed |
| Trulicity | Dulaglutide | 12 | suppressed |
| Valsartan | Valsartan | 12 | suppressed |
| Westab Plus | Pnv,calcium 72/Iron/Folic Acid | 12 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 11 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 11 | suppressed |
| Briellyn | Norethindrone-Ethin. Estradiol | 11 | suppressed |
| Diazepam | Diazepam | 11 | suppressed |
| Epinephrine | Epinephrine | 11 | suppressed |
| Fluticasone Propionate Hfa | Fluticasone Propionate | 11 | suppressed |
| Insulin Lispro | Insulin Lispro | 11 | suppressed |
| Striverdi Respimat | Olodaterol Hcl | 11 | suppressed |
| Sulindac | Sulindac | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $142.91 · 11 records | E.R. Squibb & Sons, L.L.C. | COBENFY | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with E.R. Squibb & Sons, L.L.C.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error